<p>abrdn Life Sciences Investors (NYSE:HQL - 獲取免費報告) 的股票在週一創下了新的 52 周高點。該股最高交易價為$18.10，最後交易價為$18.00，成交量為 134715 股。該股此前收盤價為$18.01。</p>
<h2>abrdn Life Sciences Investors 股票表現</h2>
<p>該公司的 50 日移動平均線為$16.76，200 日移動平均線為$16.82。</p>
<h2>abrdn Life Sciences Investors 增加股息</h2>
<p>該公司最近還披露了季度股息，已於 3 月 31 日（星期二）支付。2 月 20 日（星期五）的股東記錄將獲得$0.56 的股息。這比 abrdn Life Sciences Investors 之前的季度股息$0.50 有所增加。除息日期為 2 月 20 日（星期五）。這代表着每年$2.24 的股息和 12.5% 的收益率。</p>
<h2>機構資金流入和流出</h2>
<p>機構投資者最近對該公司的持倉進行了調整。Shaker Financial Services LLC 在第三季度將其在 abrdn Life Sciences Investors 的股份增加了 536.8%。Shaker Financial Services LLC 現在擁有 197,804 股該公司的股票，價值$3,068,000，此前在該期間購買了額外的 166,742 股。World Investment Advisors 在第三季度購買了 abrdn Life Sciences Investors 的新股份，價值約$1,440,000。LPL Financial LLC 在第四季度將其在 abrdn Life Sciences Investors 的股份增加了 20.0%。LPL Financial LLC 現在擁有 448,846 股該公司的股票，價值$7,532,000，此前在上個季度收購了額外的 74,787 股。Wolverine Asset Management LLC 在第三季度將其在 abrdn Life Sciences Investors 的股份增加了 50.8%。Wolverine Asset Management LLC 現在擁有 215,521 股該公司的股票，價值$3,343,000，此前在上個季度收購了額外的 72,601 股。最後，Landscape Capital Management L.L.C.在第四季度購買了 abrdn Life Sciences Investors 的新股份，價值約$1,158,000。機構投資者持有該公司 32.21% 的股票。</p>
<h2>關於 abrdn Life Sciences Investors</h2>
<p>(獲取免費報告)</p>
<p>abrdn Life Sciences Investors NYSE: HQL 是一家封閉式管理投資公司，旨在通過投資生命科學領域實現資本增值。該信託成立於 1994 年，專注於從事生物技術、製藥、醫療設備、診斷及相關領域的公司的股票及相關證券。其封閉式結構使投資組合經理能夠維持穩定的資本池，追求長期投資策略，並在適當時使用槓桿。</p>
<p>該基金的投資組合涵蓋公共和私人公司，重點關注推動藥物開發、基因治療、精準醫療和醫療技術創新的企業。</p>
<h2>另請參見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 abrdn Life Sciences Investors</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 abrdn Life Sciences Investors 嗎？</h2>
<p>在考慮 abrdn Life Sciences Investors 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 abrdn Life Sciences Investors 並不在名單上。</p>
<p>雖然 abrdn Life Sciences Investors 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

<p>abrdn Life Sciences Investors (NYSE:HQL) 達到了新的 52 周高點 18.10 美元，收盤價為 18.00 美元，交易量為 134,715 股。該公司最近將季度股息從 0.50 美元提高至 0.56 美元，收益率為 12.5%。機構投資者顯著增加了其持股比例，Shaker Financial Services 的持倉增長了 536.8%。abrdn Life Sciences Investors 專注於生命科學領域的資本增值，投資於生物技術、製藥和醫療技術</p>

<p>abrdn Life Sciences Investors (NYSE:HQL - Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $18.10 and last traded at $18.00, with a volume of 134715 shares. The stock had previously closed at $18.01.</p>
<div class="lb-trans"><p>abrdn Life Sciences Investors (NYSE:HQL - 獲取免費報告) 的股票在週一創下了新的 52 周高點。該股最高交易價為$18.10，最後交易價為$18.00，成交量為 134715 股。該股此前收盤價為$18.01。</p>
</div><h2>abrdn Life Sciences Investors Stock Performance</h2>
<div class="lb-trans"><h2>abrdn Life Sciences Investors 股票表現</h2>
</div><p>The company has a 50-day moving average of $16.76 and a 200 day moving average of $16.82.</p>
<div class="lb-trans"><p>該公司的 50 日移動平均線為$16.76，200 日移動平均線為$16.82。</p>
</div><h2>abrdn Life Sciences Investors Increases Dividend</h2>
<div class="lb-trans"><h2>abrdn Life Sciences Investors 增加股息</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Friday, February 20th were issued a $0.56 dividend. This is an increase from abrdn Life Sciences Investors's previous quarterly dividend of $0.50. The ex-dividend date was Friday, February 20th. This represents a $2.24 annualized dividend and a yield of 12.5%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度股息，已於 3 月 31 日（星期二）支付。2 月 20 日（星期五）的股東記錄將獲得$0.56 的股息。這比 abrdn Life Sciences Investors 之前的季度股息$0.50 有所增加。除息日期為 2 月 20 日（星期五）。這代表着每年$2.24 的股息和 12.5% 的收益率。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Institutional investors have recently made changes to their positions in the company. Shaker Financial Services LLC grew its stake in abrdn Life Sciences Investors by 536.8% in the third quarter. Shaker Financial Services LLC now owns 197,804 shares of the company's stock worth $3,068,000 after purchasing an additional 166,742 shares during the period. World Investment Advisors purchased a new stake in shares of abrdn Life Sciences Investors in the 3rd quarter worth about $1,440,000. LPL Financial LLC increased its stake in shares of abrdn Life Sciences Investors by 20.0% in the 4th quarter. LPL Financial LLC now owns 448,846 shares of the company's stock worth $7,532,000 after acquiring an additional 74,787 shares in the last quarter. Wolverine Asset Management LLC boosted its stake in abrdn Life Sciences Investors by 50.8% during the third quarter. Wolverine Asset Management LLC now owns 215,521 shares of the company's stock worth $3,343,000 after acquiring an additional 72,601 shares in the last quarter. Finally, Landscape Capital Management L.L.C. bought a new stake in abrdn Life Sciences Investors during the fourth quarter worth about $1,158,000. Institutional investors own 32.21% of the company's stock.</p>
<div class="lb-trans"><p>機構投資者最近對該公司的持倉進行了調整。Shaker Financial Services LLC 在第三季度將其在 abrdn Life Sciences Investors 的股份增加了 536.8%。Shaker Financial Services LLC 現在擁有 197,804 股該公司的股票，價值$3,068,000，此前在該期間購買了額外的 166,742 股。World Investment Advisors 在第三季度購買了 abrdn Life Sciences Investors 的新股份，價值約$1,440,000。LPL Financial LLC 在第四季度將其在 abrdn Life Sciences Investors 的股份增加了 20.0%。LPL Financial LLC 現在擁有 448,846 股該公司的股票，價值$7,532,000，此前在上個季度收購了額外的 74,787 股。Wolverine Asset Management LLC 在第三季度將其在 abrdn Life Sciences Investors 的股份增加了 50.8%。Wolverine Asset Management LLC 現在擁有 215,521 股該公司的股票，價值$3,343,000，此前在上個季度收購了額外的 72,601 股。最後，Landscape Capital Management L.L.C.在第四季度購買了 abrdn Life Sciences Investors 的新股份，價值約$1,158,000。機構投資者持有該公司 32.21% 的股票。</p>
</div><h2>About abrdn Life Sciences Investors</h2>
<div class="lb-trans"><h2>關於 abrdn Life Sciences Investors</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>abrdn Life Sciences Investors NYSE: HQL is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.</p>
<div class="lb-trans"><p>abrdn Life Sciences Investors NYSE: HQL 是一家封閉式管理投資公司，旨在通過投資生命科學領域實現資本增值。該信託成立於 1994 年，專注於從事生物技術、製藥、醫療設備、診斷及相關領域的公司的股票及相關證券。其封閉式結構使投資組合經理能夠維持穩定的資本池，追求長期投資策略，並在適當時使用槓桿。</p>
</div><p>The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.</p>
<div class="lb-trans"><p>該基金的投資組合涵蓋公共和私人公司，重點關注推動藥物開發、基因治療、精準醫療和醫療技術創新的企業。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另請參見</h2>
</div><ul>
<li>Five stocks we like better than abrdn Life Sciences Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 abrdn Life Sciences Investors</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in abrdn Life Sciences Investors Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 abrdn Life Sciences Investors 嗎？</h2>
</div><p>Before you consider abrdn Life Sciences Investors, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 abrdn Life Sciences Investors 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Life Sciences Investors wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 abrdn Life Sciences Investors 並不在名單上。</p>
</div><p>While abrdn Life Sciences Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 abrdn Life Sciences Investors 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

abrdn Life Sciences Investors（NYSE:HQL）創下 1 年新高 - 原因如下